v
v
Shortage of RNA extraction kits hampers efforts to ramp up COVID-19 coronavirus testing
Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations
v
Chemistry departments deal with coronavirus closures
Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists
v
ACS launches virtual platform for sharing research from Philadelphia national meeting
v
Tips for teaching in the time of coronavirus
Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic
v
No evidence to support link between ibuprofen and COVID-19, experts say
WHO does not recommend against taking the drug for fever caused by novel coronavirus infection
v
Ginkgo opens facilities to help COVID-19 coronavirus response
Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines
v
COVID-19 coronavirus quarantines cause rapid drop in air pollution
v
PVA-based gel removes dirt from paintings
v
How we know disinfectants should kill the COVID-19 coronavirus
The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking
v
EPA overhauls pesticide biological evaluations
v
Ilham Kadri is reshaping Solvay
The first female CEO of a European chemical major begins a financial, social, and environmental overhaul of one of the oldest chemical firms
v
Priestley Medal address 2020: The road less traveled—for love of detection, discovery, and all things radical in nature
v
Microreactor enables rapid testing of green solvents
Strategy reduces volumes and times needed to evaluate CO<sub>2</sub>-switchable systems
v
3-D printing firms rise to coronavirus challenge
Companies are making their machines and expertise available to hospitals in need of parts
v
Crystal structures of the novel coronavirus protease guide drug development
Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19
v
China's contract research firms rebound after coronavirus
v
Protein mapping finds 69 potential treatments for COVID-19
v
Eliminating catalyst defects boosts activity and extends lifetime
Nearly perfect, long-lasting crystalline catalyst turns CO<sub>2</sub> into valuable products
v
Tension but also harmony over COVID-19 in Europe's chemical industry
v
Structure of active ribonucleotide reductase solved with cryo-electron microscopy
Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism
v
Chloroquine's use to treat COVID-19 is backed by US government, but many questions remain
Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far
v
Vaping exposes users to more toxic metals than smoking cigarettes
v
Emory-discovered antiviral is poised for COVID-19 clinical trials
The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans
v
ACS launches virtual platform for sharing research from Philadelphia national meeting
v
Shortage of RNA extraction kits hampers efforts to ramp up COVID-19 testing
Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations
v
3-D printing firms rise to coronavirus challenge
Companies are making their machines and expertise available to hospitals in need of parts
v
Crystal structures of the novel coronavirus's main protease guide drug development
Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19
v
What can initial remdesivir data tell us about tackling COVID-19?
Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts
v
US stimulus bill includes funding for coronavirus research
v
Video: Chemistry turns backyard clay into a 3-D printable building material
Technology could lessen the environmental impact of 3-D printed buildings by adapting locally harvested soils
v
Chemical industry welcomes leniency from US EPA during coronavirus response
v
COVID-19 mostly behind it, China's chemical industry struggles to rev up
v
Companies are racing to develop COVID-19 tests for the US. Will they help?
With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap
v
New mapping method reveals reactions galore
v
Laser burns graphene onto Kevlar to power up protective gear
Using lasers to directly create graphene on Kevlar makes it easy to integrate electronics on textiles
v
Coronavirus starts to weigh on industry
v
What do we know about the novel coronavirus's 29 proteins?
These biomolecules could hold clues to why the virus is so infectious and to how to stop it